Different species of alpha-synuclein oligomers induce calcium influx and seeding.

Keywords

Oligomer, Synucleinopathies, Alpha-synuclein, Fibril, Chemistry

References

No references recorded for this paper.

Cited by

• Molecular Chaperones in Parkinson’s Disease – Present and FutureDarius Ebrahimi‐Fakhari, Lara Wahlster, Pamela J. McLean — 2011
• Antibodies against Alpha-Synuclein Reduce Oligomerization in Living Cells俊介 禰津, 忠輝 岩山, 哲 渡邉 — 2011
• Can Parkinson's disease pathology be propagated from one neuron to another?菜奈子 田宮, 紀子 天利, 勝敬 村田 — 2012
• Adult neurogenesis in Parkinson’s diseaseAna María Pita Grandal — 2012
• Soluble alpha-synuclein oligomers are associated with reduced synapsin expression and enhanced cognitive decline in Alzheimer's diseaseSusan Greimel — 2014
• The Impact of Genetic Research on Our Understanding of Parkinson’s DiseaseIan Martin, Valina L. Dawson, Ted M. Dawson — 2010
• A possible physiological role of Abeta as a crosslinkerRudolf Blöchl — 2008
• α-Synuclein Oligomers: an Amyloid Pore?Martin Stöckl, Niels Zijlstra, Vinod Subramaniam — 2012
• The role of alpha synuclein in Parkinson’s diseaseDima Moualla — 2011
• Toxic intermediates and protein quality control in the polyglutamine disease, SCA3Aislinn J Williams — 2010
• ASYN and tau interaction : new drug target for neurodegenerative diseasesGianmario Ciaccioli — 2014
• Synucleins and their roles in the pathology of Parkinson’s disease as metal binding proteinsXiaoyan Wang — 2009
• Alpha-synuclein in the neurodegenerative mechanisms of Parkinson's disease and dementia with Lewy bodiesR. Musgrove — 2012
• Unraveling the role of defective genesMark Cookson — 2010
• Mechanisms of amyloid fibril-mediated toxicityKevin W. Tipping — 2014
• Mutual exacerbation of PGC-1α deregulation and α-synuclein oligomerizationJudith Eschbach, Björn von Einem, Kathrin Müller — 2014
• Loss of Functional Alpha-Synuclein: A Toxic Event in Parkinson’s Disease?Nicholas M. Kanaan, Fredric P. Manfredsson — 2012
• Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in NeurodegenerationPauline Wales, Raquel Pinho, Diana F. Lázaro — 2013
• Role of α-synuclein penetration into the membrane in the mechanisms of oligomer pore formationIgor F. Tsigelny, Yuriy Sharikov, Wolfgang Wrasidlo — 2012
• Order, disorder, and protein aggregationThomas Gurry — 2015

Related papers

• Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profilesSelene Seoyun Lee, Livia Civitelli, Laura Parkkinen — 2024
• Cryo-EM structure of alpha-synuclein fibrilsRicardo Guerrero-Ferreira, Nicholas M. I. Taylor, Daniel Mona — 2018
• Alpha-synuclein and transgenic mouse models.Pierre‐Olivier Fernagut, Marie‐Françoise Chesselet — 2004
• GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting CompoundsKathrin Brockmann — 2020
• Alpha-synuclein and the prion hypothesis in Parkinson's disease.Ronald Melki — 2018
• The 3D structure of lipidic fibrils of α-synucleinBenedikt Frieg, Leif Antonschmidt, Christian Dienemann — 2022
• Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathiesAnna Villar‐Piqué, Tomás Lopes da Fonseca, Tiago F. Outeiro — 2016
• [Alpha-synucleinopathies].Isidró Ferrer — 2001
• Cryo-EM structure of alpha-synuclein fibrils amplified by PMCA from PD and MSA patient brainsDomenic Burger, Alexis Fenyi, Luc Bousset — 2021